RxDoctor Payments DataLook up a doctor →

Lori Williams, PA

Physician Assistant · Hays, KSNPI 1801869672

Payments from drug & device makers

$8,662in general payments, 2019–2025

Across 458 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$632
  • Bristol Myers Squibb$522
  • Seagen Inc.$435
  • E.r. Squibb & Sons, L.L.C.$414
  • Pfizer$402
  • Astellas Pharma US Inc$377
  • plus $6K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis35$632
Bristol Myers Squibb31$522
Seagen Inc.15$435
E.r. Squibb & Sons, L.L.C.29$414
Pfizer32$402
Astellas Pharma US Inc10$377
Gilead(2 entities)21$373
Johnson & Johnson17$372
Genentech USA, Inc.24$319
Merck15$300
GSK16$284
Amgen12$242
Sanofi9$226
AstraZeneca12$220
Array Biopharma Inc16$218
AbbVie11$212
Exelixis Inc.8$193
Tersera Therapeutics LLC6$190
Incyte Corporation10$180
Regeneron Healthcare Solutions, Inc.5$178
Lilly USA, LLC9$173
EMD Serono, Inc.12$137
Takeda Pharmaceuticals U.S.A., Inc.5$125
Sobi, Inc5$108
AVEO Pharmaceuticals, Inc.4$105
Pharmacyclics LLC, An Abbvie Company4$95
Jazz Pharmaceuticals Inc.4$87
Daiichi Sankyo Inc.4$84
Rigel Pharmaceuticals, Inc.4$83
Karyopharm Therapeutics Inc.4$72
Springworks Therapeutics, Inc.3$70
Genmab U.S., Inc.3$67
G1 Therapeutics, Inc.4$67
Puma Biotechnology, Inc.4$66
Ipsen Biopharmaceuticals, Inc3$64
Kyowa Kirin, Inc.4$64
Bayer3$61
Novocure Inc.3$60
Apellis Pharmaceuticals, Inc.3$58
Eisai Inc.3$57
Taiho Oncology, Inc.3$55
Stemline Therapeutics Inc.3$52
Emmaus Medical, Inc.2$50
Sumitomo Pharma America, Inc.2$46
Sun Pharmaceutical Industries Inc.2$45
Adaptive Biotechnologies Corporation2$43
Mylan Institutional Inc.2$42
Acrotech Biopharma Inc.3$40
Agios Pharmaceuticals, Inc.2$38
Beigene USA, Inc.3$37
Mirati Therapeutics, Inc.2$36
Epizyme, Inc.2$34
Pharmaessentia USA Corporation1$32
Geron Corporation1$21
Clovis Oncology, Inc.1$21
Genentech, Inc.1$18
Pharmacosmos Therapeutics Inc.1$17
CTI Biopharma Corp.1$15
Syndax Pharmaceuticals, Inc.1$15
Blueprint Medicines Corporation1$13

How this compares

$8,662 in reported general payments places this provider in the 95th percentile of 1,016 physician assistant providers in Kansas.

See all physician assistant providers in Kansas →

Medicare billing

Part B allowed, 2024
$60,696
Medicare patients
288
Services billed
1,013

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Hays

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →